Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knutson

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Biological Procedures Online|November 19, 2015
A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene EssentialityA R Grassian, T M E Scales, S K Knutson, et al.
The Journal of Clinical Investigation|June 14, 2024
Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteinsMeng-Hsiung Hsieh, Yonglong Wei, Lin Li, et al.
Molecular Cancer Therapeutics|March 16, 2017
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: <i>In Vitro</i> and <i>In Vivo</i> Preclinical ModelsElayne Chan-Penebre, Kelli Armstrong, Allison Drew, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2Sarah K Knutson, Natalie M Warholic, Tim J Wigle, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of TazemetostatKevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Environmental Science & Technology|August 30, 2008
Statistical comparison of residential soil concentrations of PCDDs, PCDFs, and PCBs from two communities in MichiganA Demond, P Adriaens, T Towey, et al.
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Plos One|July 9, 2016
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Mobile DNA|November 22, 2023
Proceedings of the inaugural Dark Genome Symposium: November 2022Jef D Boeke, Kathleen H Burns, Katherine B Chiappinelli, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Biological Procedures Online|November 19, 2015
A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene EssentialityA R Grassian, T M E Scales, S K Knutson, et al.
The Journal of Clinical Investigation|June 14, 2024
Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteinsMeng-Hsiung Hsieh, Yonglong Wei, Lin Li, et al.
Molecular Cancer Therapeutics|March 16, 2017
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: <i>In Vitro</i> and <i>In Vivo</i> Preclinical ModelsElayne Chan-Penebre, Kelli Armstrong, Allison Drew, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2Sarah K Knutson, Natalie M Warholic, Tim J Wigle, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of TazemetostatKevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Environmental Science & Technology|August 30, 2008
Statistical comparison of residential soil concentrations of PCDDs, PCDFs, and PCBs from two communities in MichiganA Demond, P Adriaens, T Towey, et al.
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Plos One|July 9, 2016
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Mobile DNA|November 22, 2023
Proceedings of the inaugural Dark Genome Symposium: November 2022Jef D Boeke, Kathleen H Burns, Katherine B Chiappinelli, et al.
Pageof 10